Magnesium and Metabolic Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

November 30, 2007

Conditions
Diabetes MellitusHigh Blood PressureHypomagnesemia
Interventions
DIETARY_SUPPLEMENT

Magnesium chloride

Subjects in the intervention group received 2.5 gr of MgCl2 daily during 4 months, from a solution solution containing 50 gr of MgCl2 by 1000 ml.

OTHER

Placebo

Subjects in the control group received inert placebo once per day during 4 months

Trial Locations (1)

34067

Biomedical Research Unit, Durango

All Listed Sponsors
lead

Instituto Mexicano del Seguro Social

OTHER_GOV

NCT00603499 - Magnesium and Metabolic Syndrome | Biotech Hunter | Biotech Hunter